65%Confidence
0Views
SEC EDGARSource
2026-04-08Date
Summary
Coeptis Therapeutics filed a current report, possibly related to drug development progress or capital raises in the immuno-oncology field. Such updates are crucial for small-cap biotech investor sentiment.
Actionable: Look for regulatory or partnership news that could drive short-term stock volatility.
AI Confidence: 65%
Data Points
companyCoeptis Therapeutics Holdings, Inc. (COEP, COEPW) (CIK 0001759186)
form8-K
date2026-04-08
Get Signals Instantly
Premium subscribers receive every signal via Telegram the moment it fires — hours before it appears here.
Subscribe Now